Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 708158, 9 pages
http://dx.doi.org/10.1155/2015/708158
Research Article

Translational Control Protein 80 Stimulates IRES-Mediated Translation of p53 mRNA in Response to DNA Damage

1The Hormel Institute, University of Minnesota, Austin, MN 55912, USA
2Cancer Biology Research Center, Sanford Research/University of South Dakota, Sioux Falls, SD 57104, USA
3The Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA

Received 29 November 2014; Revised 8 March 2015; Accepted 9 March 2015

Academic Editor: Peter Jordan

Copyright © 2015 Marie-Jo Halaby et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Vogelstein, D. Lane, and A. J. Levine, “Surfing the p53 network,” Nature, vol. 408, no. 6810, pp. 307–310, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. A. J. Giaccia and M. B. Kastan, “The complexity of p53 modulation: emerging patterns from divergent signals,” Genes and Development, vol. 12, no. 19, pp. 2973–2983, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. M. E. Ewen and S. J. Miller, “p53 and translational control,” Biochimica et Biophysica Acta—Reviews on Cancer, vol. 1242, no. 3, pp. 181–184, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. M.-J. Halaby and D.-Q. Yang, “p53 translational control: a new facet of p53 regulation and its implication for tumorigenesis and cancer therapeutics,” Gene, vol. 395, no. 1-2, pp. 1–7, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Grover, M. M. Candeias, R. Fhraeus, and S. Das, “P53 and little brother p53/47: linking IRES activities with protein functions,” Oncogene, vol. 28, no. 30, pp. 2766–2772, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Mosner, T. Mummenbrauer, C. Bauer, G. Sczakiel, F. Grosse, and W. Deppert, “Negative feedback regulation of wild-type p53 biosynthesis,” The EMBO Journal, vol. 14, no. 18, pp. 4442–4449, 1995. View at Google Scholar · View at Scopus
  7. L. Fu and S. Benchimol, “Participation of the human p53 3'UTR in translational repression and activation following γ-irradiation,” The EMBO Journal, vol. 16, no. 13, pp. 4117–4125, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. D.-Q. Yang, M.-J. Halaby, and Y. Zhang, “The identification of an internal ribosomal entry site in the 5′-untranslated region of p53 mRNA provides a novel mechanism for the regulation of its translation following DNA damage,” Oncogene, vol. 25, no. 33, pp. 4613–4619, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. A. C. Gingras, B. Raught, and N. Sonenberg, “eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation,” Annual Review of Biochemistry, vol. 68, pp. 913–963, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Yang, G. J. Brunn, and J. C. Lawrence Jr., “Mutational analysis of sites in the translational regulator, PHAS-I, that are selectively phosphorylated by mTOR,” FEBS Letters, vol. 453, no. 3, pp. 387–390, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. I. Mothe-Satney, D. Yang, P. Fadden, T. A. J. Haystead, and J. C. Lawrence Jr., “Multiple mechanisms control phosphorylation of PHAS-I in five (S/T)P sites that govern translational repression,” Molecular and Cellular Biology, vol. 20, no. 10, pp. 3558–3567, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. C. U. T. Hellen and P. Sarnow, “Internal ribosome entry sites in eukaryotic mRNA molecules,” Genes and Development, vol. 15, no. 13, pp. 1593–1612, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. A. B. Sachs, “Cell cycle-dependent translation initiation: IRES elements prevail,” Cell, vol. 101, no. 3, pp. 243–245, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Stoneley and A. E. Willis, “Cellular internal ribosome entry segments: structures, trans-acting factors and regulation of gene expression,” Oncogene, vol. 23, no. 18, pp. 3200–3207, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Holcik and N. Sonenberg, “Translational control in stress and apoptosis,” Nature Reviews Molecular Cell Biology, vol. 6, no. 4, pp. 318–327, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. K. W. Sherrill, M. P. Byrd, M. E. van Eden, and R. E. Lloyd, “BCL-2 translation is mediated via internal ribosome entry during cell stress,” The Journal of Biological Chemistry, vol. 279, no. 28, pp. 29066–29074, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. N. H. Ungureanu, M. Cloutier, S. M. Lewis et al., “Internal ribosome entry site-mediated translation of Apaf-1, but not XIAP, is regulated during UV-induced cell death,” The Journal of Biological Chemistry, vol. 281, no. 22, pp. 15155–15163, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. P. S. Ray, R. Grover, and S. Das, “Two internal ribosome entry sites mediate the translation of p53 isoforms,” EMBO Reports, vol. 7, no. 4, pp. 404–410, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. M. M. Candeias, D. J. Powell, E. Roubalova et al., “Expression of p53 and p53/47 are controlled by alternative mechanisms of messenger RNA translation initiation,” Oncogene, vol. 25, no. 52, pp. 6936–6947, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. A. E. Sayan, J. P. Roperch, B. S. Sayan et al., “Generation of ΔTAp73 proteins by translation from a putative internal ribosome entry site,” Annals of the New York Academy of Sciences, vol. 1095, pp. 315–324, 2007. View at Publisher · View at Google Scholar
  21. L. Montanaro, M. Calienni, S. Bertoni et al., “Novel dyskerin-mediated mechanism of p53 inactivation through defective mRNA translation,” Cancer Research, vol. 70, no. 11, pp. 4767–4777, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Bellodi, N. Kopmar, and D. Ruggero, “Deregulation of oncogene-induced senescence and p53 translational control in X-linked dyskeratosis congenita,” The EMBO Journal, vol. 29, no. 11, pp. 1865–1876, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Wedeken, P. Singh, and K.-H. Klempnauer, “Tumor suppressor protein Pdcd4 inhibits translation of p53 mRNA,” The Journal of Biological Chemistry, vol. 286, no. 50, pp. 42855–42862, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Sharathchandra, R. Lal, D. Khan, and S. Das, “Annexin A2 and PSF proteins interact with p53 IRES and regulate translation of p53 mRNA,” RNA Biology, vol. 9, no. 12, pp. 1429–1439, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. D.-Y. Kim, W. Kim, K.-H. Lee et al., “hnRNP Q regulates translation of p53 in normal and stress conditions,” Cell Death and Differentiation, vol. 20, no. 2, pp. 226–234, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Grover, A. Sharathchandra, A. Ponnuswamy, D. Khan, and S. Das, “Effect of mutations on the p53 IRES RNA structure: implications for de-regulation of the synthesis of p53 isoforms,” RNA Biology, vol. 8, no. 1, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Grover, P. S. Ray, and S. Das, “Polypyrimidine tract binding protein regulates IRES-mediated translation of p53 isoforms,” Cell Cycle, vol. 7, no. 14, pp. 2189–2198, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Khan, A. Katoch, A. Das et al., “Reversible induction of translational isoforms of p53 in glucose deprivation,” Cell Death and Differentiation, 2015. View at Publisher · View at Google Scholar
  29. R. J. Jackson, “Alternative mechanisms of initiating translation of mammalian mRNAs,” Biochemical Society Transactions, vol. 33, no. 6, pp. 1231–1241, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Takagi, M. J. Absalon, K. G. McLure, and M. B. Kastan, “Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin,” Cell, vol. 123, no. 1, pp. 49–63, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. S. A. Tenenbaum, P. J. Lager, C. C. Carson, and J. D. Keene, “Ribonomics: identifying mRNA subsets in mRNP complexes using antibodies to RNA-binding proteins and genomic arrays,” Methods, vol. 26, no. 2, pp. 191–198, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. I. Fierro-Monti and M. B. Mathews, “Proteins binding to duplexed RNA: one motif, multiple functions,” Trends in Biochemical Sciences, vol. 25, no. 5, pp. 241–246, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. H. Xu and G. A. Grabowski, “Molecular cloning and characterization of a translational inhibitory protein that binds to coding sequences of human acid beta-glucosidase and other mRNAs,” Molecular Genetics and Metabolism, vol. 68, no. 4, pp. 441–454, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. M. K. Merrill and M. Gromeier, “The double-stranded RNA binding protein 76:NF45 heterodimer inhibits translation initiation at the rhinovirus type 2 internal ribosome entry site,” Journal of Virology, vol. 80, no. 14, pp. 6936–6942, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. L. M. Parker, I. Fierro-Monti, and M. B. Mathews, “Nuclear factor 90 is a substrate and regulator of the eukaryotic initiation factor 2 kinase double-stranded RNA-activated protein kinase,” Journal of Biological Chemistry, vol. 276, no. 35, pp. 32522–32530, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. B. Tian, P. C. Bevilacqua, A. Diegelman-Parente, and M. B. Mathews, “The double-stranded-RNA-binding motif: interference and much more,” Nature Reviews Molecular Cell Biology, vol. 5, no. 12, pp. 1013–1023, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. T. W. Reichman, A. M. Parrott, I. Fierro-Monti et al., “Selective regulation of gene expression by nuclear factor 110, a member of the NF90 family of double-stranded RNA-binding proteins,” Journal of Molecular Biology, vol. 332, no. 1, pp. 85–98, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. T. R. Hartman, S. Qian, C. Bolinger, S. Fernandez, D. R. Schoenberg, and K. Boris-Lawrie, “RNA helicase A is necessary for translation of selected messenger RNAs,” Nature Structural & Molecular Biology, vol. 13, no. 6, pp. 509–516, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. T. W. Reichman and M. B. Mathews, “RNA binding and intramolecular interactions modulate the regulation of gene expression by nuclear factor 110,” RNA, vol. 9, no. 5, pp. 543–554, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. V. Neplioueva, E. Y. Dobrikova, N. Mukherjee, J. D. Keene, and M. Gromeier, “Tissue type-specific expression of the dsRNA-binding protein 76 and genome-wide elucidation of its target mRNAs,” PLoS ONE, vol. 5, no. 7, Article ID e11710, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. C. G. Lee, T. Eki, K. Okumura et al., “The human RNA helicase A (DDX9) gene maps to the prostate cancer susceptibility locus at chromosome band 1q25 and its pseudogene (DDX9P) to 13q22, respectively,” Somatic Cell and Molecular Genetics, vol. 25, no. 1, pp. 33–39, 2000. View at Google Scholar · View at Scopus
  42. S. Zhang, P. Hemmerich, and F. Grosse, “Werner syndrome helicase (WRN), nuclear DNA helicase II (NDH II) and histone γH2AX are localized to the centrosome,” Cell Biology International, vol. 31, no. 10, pp. 1109–1121, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Zhang, B. Schlott, M. Görlach, and F. Grosse, “DNA-dependent protein kinase (DNA-PK) phosphorylates nuclear DNA helicase II/RNA helicase A and hnRNP proteins in an RNA-dependent manner,” Nucleic Acids Research, vol. 32, no. 1, pp. 1–10, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. K. H. Vousden and C. Prives, “P53 and prognosis: new insights and further complexity,” Cell, vol. 120, no. 1, pp. 7–10, 2005. View at Publisher · View at Google Scholar · View at Scopus